Endocrinology

Metabolic Syndrome

More in Metabolic Syndrome

75% of Adults Overweight or Obese; Global Diabetes Tx Lacking; Hidden Bone Data?

News and commentary from the endocrinology world

Nov 19, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Over 50% of U.S. Adults Qualify for Ozempic, Wegovy

Most are eligible for weight management indication

Nov 18, 2024
AHA over a photo of McCormick Place Convention Center in Chicago, IL.
16% of Adults Have Diabetes; Compounded Semaglutide Deaths; Testosterone Tx Surge

News and commentary from the endocrinology world

Nov 12, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Patients With Obesity Shed Pounds With Drug-Free Capsule

Participants also had improved cardiometabolic measures with Epitomee device

Nov 08, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
Zepbound's Weight Loss, Cardiometabolic Benefits Hold Up at 3 Years

Nearly all participants in SURMOUNT-1 avoided diabetes with the GLP-1/GIP receptor agonist

Nov 07, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
Early-Life Sugar Restriction Reduced Diabetes, Hypertension Risk

Diagnoses were also delayed the longer sugar was restricted

Nov 06, 2024
ObesityWeek over a photo of Henry B. González Convention Center in San Antonio, TX.
CGM OK'd During Medical Imaging; All Semaglutide Doses Back; Bariatric Surgery Down

News and commentary from the endocrinology world

Nov 05, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Weight Loss After Bariatric Surgery in Teens Persisted at 10 Years

Remission of coexisting conditions was also maintained, long-term data show

Oct 30, 2024
A photo of surgeons performing laparoscopic bariatric surgery.
Wegovy Cut Albuminuria by Half in Non-Diabetic CKD

However, 24 weeks of the GLP-1 had no impact on eGFR

Oct 29, 2024
ASN over a photo of San Diego Convention Center in San Diego, CA.
Scripts for GLP-1, SGLT2 Drugs on the Rise in Type 1 Diabetes Patients

Findings leave researcher "concerned"

Oct 23, 2024
A photo of a woman holding out a semaglutide injection pen.
Acromegaly Injectable Rejected; Nobel Prize Winner Dies; Obesity Doubles in Kids

News and commentary from the endocrinology world

Oct 22, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Obesity Epidemic Peaked? FDA Reviews Menopause Drug; Metabolic Surgery and Cancer

News and commentary from the endocrinology world

Oct 15, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
Weekend Warrior Benefits; Time-Restricted Eating and Metabolic Syndrome

Also in TTHealthWatch: menopause hormone therapy in the U.S.

Oct 12, 2024
TTUHSC EL PASO HEALTHWATCH with their logo and photos of Rick Lange, MD, and Elizabeth Tracey
Tirzepatide Shortage Resolved; Compounder Sues FDA; Menopause Mistaken as Dementia

News and commentary from the endocrinology world

Oct 08, 2024
Endo Break over a computer rendering of a man with illustrated body organs.
More in Metabolic Syndrome

0.50 CME Credits
Adjuvant Endocrine Therapy in HR+ Breast Cancer: Enhancing Quality Care and Patient Outcomes

0.75 CME Credits
Navigating Endocrine Resistance: Latest Strategies in HR+/HER2- Breast Cancer Care

0.25 CME Credits
Applying the Latest Evidence to Overcome Endocrine Resistance in HR+/HER2- Breast Cancer

0.50 CME Credits
Examining the Pathophysiology, Burden, and Evolving Treatment Landscape of Acromegaly

0.50 CME Credits
Enhancing Acromegaly Care Through Integration of the Latest Clinical Evidence and Patient-Centered Management

0.50 CME Credits
Cutting-Edge Treatment Approaches for Patients With T1D and Impaired Awareness of Hypoglycemia (IAH)

0.50 CME Credits
Breakthroughs in Severe Hypertriglyceridemia and Familial Chylomicronemia Syndrome Management: Key Findings From ACC 2024

1.00 CME Credits
Navigating Cardiovascular Risk: The Critical Role of Lipoprotein(a) Screening and Treatment